Banco Bilbao Vizcaya Argentaria, S.A. Gilead Sciences, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

$7.82 Billion
Q2 2024

A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 585,684 shares of GILD stock, worth $49 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

585,684

Previous 572,020 2.39%

Holding current value

$49 Million

Previous $41.9 Million 4.1%

% of portfolio

0.51%

Previous 0.57%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $862,881 - $995,832	13,664 Added 2.39%	585,684 $40.2 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $161,770 - $197,275	2,260 Added 0.4%	572,020 $41.9 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $855,134 - $969,743	11,671 Added 2.09%	569,760 $46.2 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $108,691 - $118,584	-1,470 Reduced 0.26%	558,089 $41.8 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $1.45 Million - $1.65 Million	19,049 Added 3.52%	559,559 $43.1 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $2.84 Million - $3.23 Million	36,715 Added 7.29%	540,510 $44.8 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $1.16 Million - $1.67 Million	18,658 Added 3.85%	503,795 $43.3 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.29 Million - $1.47 Million	-21,616 Reduced 4.27%	485,137 $29.9 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $3.09 Million - $3.48 Million	53,491 Added 11.8%	506,753 $31.3 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $6.3 Million - $7.89 Million	108,740 Added 31.56%	453,262 $27.7 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $15.9 Million - $18 Million	244,659 Added 244.99%	344,522 $25.3 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $2.39 Million - $2.58 Million	35,379 Added 54.86%	99,863 $6.99 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $1.57 Million - $1.72 Million	-24,752 Reduced 27.74%	64,484 $4.43 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $1.42 Million - $1.62 Million	-23,600 Reduced 20.92%	89,236 $5.79 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $1.39 Million - $1.59 Million	-24,566 Reduced 17.88%	112,836 $6.57 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $5.76 Million - $7.24 Million	92,695 Added 207.34%	137,402 $8.68 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $1.78 Million - $2.07 Million	-24,667 Reduced 35.56%	44,707 $3.44 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $816,319 - $1.05 Million	-13,034 Reduced 15.82%	69,374 $5.19 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $5.08 Million - $5.59 Million	82,408 New	82,408 $5.35 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.

Account

Banco Bilbao Vizcaya Argentaria, S.A. Gilead Sciences, Inc. Transaction History